Six of our dedicated consultants were involved in a market research project with Bilthoven Biologicals (BBio), a carve-out of the former Netherlands Vaccine Institute acquired by Serum Institute of India in 2012. Since then, BBio has been focusing predominantly on the production of polio vaccines supporting the WHO’s Global Polio Eradication Initiative. Born out of the visionary efforts of Dr Cyrus Ponnawalla, the Serum Institute of India is the world’s largest producer of vaccines. With a remarkable production of over 1.5 billion doses, they cover a spectrum of vaccines reaching about 65% of children worldwide in about 170 countries.
Our Graduate Consultants were actively involved in an extensive project with BBio, focusing on product and market assessments. Their goal was to formulate a strategy to open up new markets for these vaccines, making these high-quality products more widely accessible. This joint initiative represents a collaborative effort to improve global access and distribution of essential vaccines.
